OrbiMed Israel BioFund GP Limited Partnership is 10% Owner at INNOVATE BIOPHARMACEUTICALS, INC. (NMTR). They have made 4 open-market trades across 4 companies since 2019, most recently 2023-01-03.
CIK 0001569821
2 open-market purchases totalling $2.1M since 2019, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.